PubMed

Intensification with prandial insulin.

Pfützner A, Forst T.

Int J Clin Pract. 2009 Oct;63(s164Insulin Intensification Summit):11-14.PMID: 19930415 [PubMed - as supplied by publisher]

Differences in the results and interpretation of oxidized LDL cholesterol by two ELISA assays--an evaluation with samples from the PIOstat study.

Pfützner A, Efstrathios K, Löbig M, Armbruster FP, Hanefeld M, Forst T.

Clin Lab. 2009;55(7-8):275-81.PMID: 19894406 [PubMed - in process]Related articles

Reliability of Lightguide Spectrophotometry (O2C) for the Investigation of Skin Tissue Microvascular Blood Flow and Tissue Oxygen Supply in Diabetic and Nondiabetic Subjects.

Forst T, Hohberg C, Tarakci E, Forst S, Kann P, Pfützner A.

J Diabetes Sci Technol. 2008 Nov;2(6):1151-6.PMID: 19885305 [PubMed - in process]Free article

Resolution of adiponectin oligomers in human plasma using free flow electrophoresis.

Foucher AL, Hartmann K, Hauptmann M, Wildgruber R, Safinowski M, Forst T, Pfützner A, Gelfand CA, Nissum M.

Arch Physiol Biochem. 2009 Nov 2. [Epub ahead of print]PMID: 19883214 [PubMed - as supplied by publisher]Related articles

Time-action profile and patient assessment of inhaled insulin via the Exubera device in comparison with subcutaneously injected insulin aspart via the FlexPen device.

Forst T, Hohberg C, Schöndorf T, Borchert M, Forst S, Roth W, Dehos B, Pfützner A.

Diabetes Technol Ther. 2009 Feb;11(2):87-92.PMID: 19848574 [PubMed - in process]Related articles

Postprandial Vascular Effects of ViajectTM compared with Insulin Lispro and Regular Human Insulin in Patients with Type 2 Diabetes Mellitus.

Forst T, Pfützner A, Flacke F, Krasner A, Hohberg C, Tarakci E, Pichotta P, Forst S, Steiner S.

Diabetes Care. 2009 Oct 6. [Epub ahead of print]PMID: 19808913 [PubMed - as supplied by publisher]Related articles

Intensification with prandial insulin.

Pfützner A, Forst T.

Int J Clin Pract Suppl. 2009 Oct;(164):11-4.PMID: 19751454 [PubMed - in process]Related articles

Competact, a fixed combination of pioglitazone and metformin, improves metabolic markers in type 2 diabetes patients with insufficient glycemic control by metformin alone--results from a post-marketing surveillance trial under daily routine conditions.

Schöndorf T, Karagiannis E, Posseldt RE, Forst T, Pfützner A.

Diabetes Technol Ther. 2009 Jun;11(6):379-83.PMID: 19459767 [PubMed - indexed for MEDLINE]Related articles

Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual beta-cell function: results from the PioSwitch study.

Hohberg C, Pfützner A, Forst T, Lübben G, Karagiannis E, Borchert M, Schöndorf T.

Diabetes Obes Metab. 2009 May;11(5):464-71.PMID: 19422402 [PubMed - in process]Related articles

Physicochemical features of ultra-high viscosity alginates.

Storz H, Müller KJ, Ehrhart F, Gómez I, Shirley SG, Gessner P, Zimmermann G, Weyand E, Sukhorukov VL, Forst T, Weber MM, Zimmermann H, Kulicke WM, Zimmermann U.

Carbohydr Res. 2009 May 26;344(8):985-95. Epub 2009 Feb 25.PMID: 19394590 [PubMed - indexed for MEDLINE]Related articles

[Challenge in diabetes therapy: effects of glitazones beyond blood glucose control]

Schernthaner G, Forst T, Gulba D, Haberbosch W, Hanefeld M, Linss G, März W, Mehnert H, Rosak C, Schnell O, Seufert J, Tschöpe D, Erdmann E.

Dtsch Med Wochenschr. 2009 Apr;134(18):949-54. Epub 2009 Apr 21. Review. German. PMID: 19384816 [PubMed - indexed for MEDLINE]Related articles

Development and validation of a high-throughput screening method for two polymorphisms in the serotonin transporter gene.

Eidens M, Weise A, Prause S, Dahmen N, Wunsch A, Weber MM, Forst T, Pfützner A.

Mol Diagn Ther. 2009;13(1):25-9. doi: 10.2165/01250444-200913010-00005.PMID: 19351213 [PubMed - indexed for MEDLINE]Related articles

Determination of nitrotyrosine concentrations in plasma samples of diabetes mellitus patients by four different immunoassays leads to contradictive results and disqualifies the majority of the tests.

Safinowski M, Wilhelm B, Reimer T, Weise A, Thomé N, Hänel H, Forst T, Pfützner A.

Clin Chem Lab Med. 2009;47(4):483-8.PMID: 19284298 [PubMed - indexed for MEDLINE]Related articles

Changes in insulin resistance and cardiovascular risk induced by PPARgamma activation have no impact on RBP4 plasma concentrations in nondiabetic patients.

Pfützner A, Schöndorf T, Hanefeld M, Lübben G, Kann PH, Karagiannis E, Wilhelm B, Forst T.

Horm Metab Res. 2009 Mar;41(3):202-6. Epub 2009 Feb 17.PMID: 19224430 [PubMed - indexed for MEDLINE]Related articles

A biomarker concept for assessment of insulin resistance, beta-cell function and chronic systemic inflammation in type 2 diabetes mellitus.

Pfützner A, Weber MM, Forst T.

Clin Lab. 2008;54(11-12):485-90. Review.PMID: 19216254 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patients.

Forst T, Hohberg C, Pfützner A.

Horm Metab Res. 2009 Feb;41(2):123-31. Epub 2009 Feb 12. Review.PMID: 19214922 [PubMed - indexed for MEDLINE]Related articles

Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk.

Forst T, Wilhelm B, Pfützner A, Fuchs W, Lehmann U, Schaper F, Weber M, Müller J, Konrad T, Hanefeld M.

Diab Vasc Dis Res. 2008 Nov;5(4):298-303.PMID: 18958840 [PubMed - indexed for MEDLINE]Related articles

Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery disease.

Pfützner A, Marx N, Walcher D, Löbig M, Seidel D, Forst T.

Clin Lab. 2008;54(7-8):237-41.PMID: 18942491 [PubMed - indexed for MEDLINE]Related articles

New tricks by an old dog.

Forst T, Wahren J.

Exp Diabetes Res. 2008;2008:384219. No abstract available. PMID: 18810274 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated peripheral visfatin levels in narcoleptic patients.

Dahmen N, Manderscheid N, Helfrich J, Musholt PB, Forst T, Pfützner A, Engel A.

PLoS One. 2008 Aug 20;3(8):e2980.PMID: 18714344 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of C-Peptide in the regulation of microvascular blood flow.

Forst T, Kunt T, Wilhelm B, Weber MM, Pfützner A.

Exp Diabetes Res. 2008;2008:176245. Review.PMID: 18670621 [PubMed - indexed for MEDLINE]Related articlesFree article

C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients.

Hach T, Forst T, Kunt T, Ekberg K, Pfützner A, Wahren J.

Exp Diabetes Res. 2008;2008:730594.PMID: 18483566 [PubMed - indexed for MEDLINE]Related articlesFree article

The IRIS V study: pioglitazone improves systemic chronic inflammation in patients with type 2 diabetes under daily routine conditions.

Karagiannis E, Pfützner A, Forst T, Lübben G, Roth W, Grabellus M, Flannery M, Schöndorf T.

Diabetes Technol Ther. 2008 Jun;10(3):206-12.PMID: 18473695 [PubMed - indexed for MEDLINE]Related articles

Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT study.

Leonhardt W, Pfützner A, Müller J, Pietzsch J, Forst T, Karagiannis E, Lübben G, Hanefeld M.

Atherosclerosis. 2008 Nov;201(1):155-62. Epub 2008 Apr 18.PMID: 18374336 [PubMed - in process]Related articles

Pioglitazone Improves Metabolic Markers in Patients with Type 2 Diabetes Independently from Physical Activities: Results from the IRIS III Study.

Schöndorf T, Pfützner A, Lübben G, Karagiannis E, Roth W, Forst T.

J Diabetes Sci Technol. 2008 Mar;2(2):244-9.PMID: 19885350 [PubMed - in process]Free article

Effect of insulin glulisine on microvascular blood flow and endothelial function in the postprandial state.

Hohberg C, Forst T, Larbig M, Safinowski M, Diessel S, Hehenwarter S, Weber MM, Schöndorf T, Pfützner A.

Diabetes Care. 2008 May;31(5):1021-5. Epub 2008 Feb 11.PMID: 18268067 [PubMed - indexed for MEDLINE]Related articlesFree article

[Determining the current position regarding the value of pioglitazone for the therapy of diabetes]

Eckert S, Erdmann E, Lundershausen R, Forst T, Scherbaum WA, Schnell O, Standl E, Schumm-Draeger PM, Tschöpe D, Walter H, Weber M.

Dtsch Med Wochenschr. 2007 Dec;132(49):2650-3. German. No abstract available. PMID: 18050033 [PubMed - indexed for MEDLINE]Related articles

The beta-Specific Protein Kinase C Inhibitor Ruboxistaurin (LY333531) Suppresses Glucose-Induced Adhesion of Human Monocytes to Endothelial Cells in Vitro.

Kunt T, Forst T, Kazda C, Harzer O, Engelbach M, Löbig M, Beyer J, Pfützner A.

J Diabetes Sci Technol. 2007 Nov;1(6):929-35.PMID: 19885168 [PubMed - in process]Free article

Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk -- results from the PIOSTAT study.

Pfützner A, Hanefeld M, Lübben G, Weber MM, Karagiannis E, Köhler C, Hohberg C, Forst T.

Horm Metab Res. 2007 Oct;39(10):764-8.PMID: 17952841 [PubMed - indexed for MEDLINE]Related articles

Review of the pleiotropic effects of peroxisome proliferator-activated receptor gamma agonists on platelet function.

Borchert M, Schöndorf T, Lübben G, Forst T, Pfützner A.

Diabetes Technol Ther. 2007 Oct;9(5):410-20. Review.PMID: 17931049 [PubMed - indexed for MEDLINE]Related articles

Peripheral leptin levels in narcoleptic patients.

Dahmen N, Engel A, Helfrich J, Manderscheid N, Löbig M, Forst T, Pfützner A, Tonn P.

Diabetes Technol Ther. 2007 Aug;9(4):348-53.PMID: 17705690 [PubMed - indexed for MEDLINE]Related articles

Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects.

Pfützner A, Weber MM, Forst T.

Expert Opin Pharmacother. 2007 Aug;8(12):1985-98. Review.PMID: 17696799 [PubMed - indexed for MEDLINE]Related articles

Preoperative diagnosis of insulinoma: low body mass index, young age, and female gender are associated with negative imaging by endoscopic ultrasound.

Kann PH, Ivan D, Pfützner A, Forst T, Langer P, Schaefer S.

Eur J Endocrinol. 2007 Aug;157(2):209-13.PMID: 17656600 [PubMed - indexed for MEDLINE]Related articlesFree article

Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type 2 diabetes mellitus.

Schöndorf T, Lübben G, Hoopmann M, Borchert M, Forst T, Hohberg C, Löbig M, Armbruster FP, Roth W, Grabellus M, Pfützner A.

Gynecol Endocrinol. 2007 Jun;23(6):356-60.PMID: 17616862 [PubMed - indexed for MEDLINE]Related articles

Endothelial Function and Arterial Stiffness in Uncomplicated Type 1 Diabetes and Healthy Controls and the Impact of Insulin on These Parameters during an Euglycemic Clamp.

Wilhelm B, Weber MM, Kreisselmeier HP, Kugler M, Ries C, Pfützner A, Kann PH, Forst T.

J Diabetes Sci Technol. 2007 Jul;1(4):582-9.PMID: 19885122 [PubMed - in process]Free article

Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease.

Forst T, Karagiannis E, Lübben G, Hohberg C, Schöndorf T, Dikta G, Drexler M, Morcos M, Dänschel W, Borchert M, Pfützner A.

Atherosclerosis. 2008 Mar;197(1):311-7. Epub 2007 Jun 22.PMID: 17588584 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone and glimeperide: review of clinical results supporting a fixed dose combination.

Pfützner A, Wilhelm B, Forst T.

Vasc Health Risk Manag. 2007;3(2):211-20. Review.PMID: 17580731 [PubMed - indexed for MEDLINE]Related articlesFree article

Development and validation of a new measure to evaluate psychological resistance to insulin treatment.

Petrak F, Stridde E, Leverkus F, Crispin AA, Forst T, Pfützner A.

Diabetes Care. 2007 Sep;30(9):2199-204. Epub 2007 Jun 15.PMID: 17575092 [PubMed - indexed for MEDLINE]Related articlesFree article

Relaxin expression correlates significantly with serum changes in VEGF in response to antidiabetic treatment in male patients with type 2 diabetes mellitus.

Schöndorf T, Forst T, Hohberg C, Lübben G, Armbruster FP, Roth W, Borchert M, Köder C, Löbig M, Grabellus M, Pfützner A.

Clin Lab. 2007;53(3-4):193-8.PMID: 17447657 [PubMed - indexed for MEDLINE]Related articles

Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain.

Forst T, Smith T, Schütte K, Marcus P, Pfützner A; CNS 5161 Study Group.

Br J Clin Pharmacol. 2007 Jul;64(1):75-82. Epub 2007 Mar 28.PMID: 17391323 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT Study.

Forst T, Pfützner A, Lübben G, Weber M, Marx N, Karagiannis E, Koehler C, Baurecht W, Hohberg C, Hanefeld M.

Metabolism. 2007 Apr;56(4):491-6.PMID: 17379006 [PubMed - indexed for MEDLINE]Related articles

[Evidence based medicine: theoretical bases and current misuse for cost cutting in the public health sector]

Pfützner A, Forst T, März W, Jacob S.

Internist (Berl). 2007 Apr;48(4):426-35. German. PMID: 17364168 [PubMed - indexed for MEDLINE]Related articles

Increased arterial augmentation and augmentation index as surrogate parameters for arteriosclerosis in subjects with diabetes mellitus and nondiabetic subjects with cardiovascular disease.

Wilhelm B, Klein J, Friedrich C, Forst S, Pfützner A, Kann PH, Weber MM, Forst T.

J Diabetes Sci Technol. 2007 Mar;1(2):260-3.PMID: 19888415 [PubMed - in process]Free article

Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.

Steiner CA, Janez A, Jensterle M, Reisinger K, Forst T, Pfützner A.

J Diabetes Sci Technol. 2007 Mar;1(2):211-7.PMID: 19888409 [PubMed - in process]Free article

Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.

Hanefeld M, Marx N, Pfützner A, Baurecht W, Lübben G, Karagiannis E, Stier U, Forst T.

J Am Coll Cardiol. 2007 Jan 23;49(3):290-7. Epub 2007 Jan 8.PMID: 17239709 [PubMed - indexed for MEDLINE]Related articles

The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight.

Schöndorf T, Forst T, Hohberg C, Pahler S, Link C, Roth W, Pfützner A, Lübben G, Link C, Pfützner A.

Diabetes Obes Metab. 2007 Jan;9(1):132-3. No abstract available. PMID: 17199730 [PubMed - indexed for MEDLINE]Related articles

Self-Monitoring of Blood Glucose Levels Requires Intensive Training for use of Meters to Obtain Reliable and Clinically Relevant Measurements.

Mohr TA, Pfützner A, Forst S, Forst T, Schöndorf T.

J Diabetes Sci Technol. 2007 Jan;1(1):56-61.PMID: 19888381 [PubMed - in process]Free article

A fast and reliable single-run method for genotyping of the human cytochrome P450 2C8 gene for different ethnic groups.

Weise A, Lambertz U, Thomé N, Bartz U, Krefft M, Mockenhaupt F, Bienzle U, Schöndorf T, Forst T, Pfützner A.

Clin Lab. 2006;52(11-12):599-603.PMID: 17175891 [PubMed - indexed for MEDLINE]Related articles

[Current laboratory parameters in the differential diagnosis of type 2 diabetes mellitus. Proinsulin, adiponectin and others]

Forst T, Pfützner A.

Dtsch Med Wochenschr. 2006 Dec;131 Suppl 8:S268-73. Review. German. PMID: 17139585 [PubMed - indexed for MEDLINE]Related articles

Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy.

Pfützner J, Forst T, Butzer R, Forst S, Weber MM, Pfützner AH, Pfützner A.

Diabet Med. 2006 Oct;23(10):1124-9.PMID: 16978378 [PubMed - indexed for MEDLINE]Related articles